Clinical Trial Update: VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

View source ↗

Summary

A study protocol investigating CMV and TTV biomarkers in allogeneic hematopoietic stem cell transplant recipients; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, CMV | Status: NOT_YET_RECRUITING